XCUR
Price
$3.62
Change
-$0.38 (-9.50%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
25.27M
XFOR
Price
$3.06
Change
-$0.15 (-4.67%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
72.06M
Interact to see
Advertisement

XCUR vs XFOR

Header iconXCUR vs XFOR Comparison
Open Charts XCUR vs XFORBanner chart's image
Exicure
Price$3.62
Change-$0.38 (-9.50%)
Volume$303
Capitalization25.27M
X4 Pharmaceuticals
Price$3.06
Change-$0.15 (-4.67%)
Volume$9.09K
Capitalization72.06M
XCUR vs XFOR Comparison Chart in %
Loading...
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
XCUR vs. XFOR commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is XCUR is a Hold and XFOR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (XCUR: $3.62 vs. XFOR: $3.04)
Brand notoriety: XCUR and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: XCUR: 47% vs. XFOR: 8%
Market capitalization -- XCUR: $25.27M vs. XFOR: $72.06M
XCUR [@Biotechnology] is valued at $25.27M. XFOR’s [@Biotechnology] market capitalization is $72.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

XCUR’s FA Score shows that 0 FA rating(s) are green whileXFOR’s FA Score has 0 green FA rating(s).

  • XCUR’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, XCUR is a better buy in the long-term than XFOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

XCUR’s TA Score shows that 4 TA indicator(s) are bullish while XFOR’s TA Score has 4 bullish TA indicator(s).

  • XCUR’s TA Score: 4 bullish, 4 bearish.
  • XFOR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, XCUR is a better buy in the short-term than XFOR.

Price Growth

XCUR (@Biotechnology) experienced а -2.95% price change this week, while XFOR (@Biotechnology) price change was -10.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XFOR($72.1M) has a higher market cap than XCUR($25.3M). XFOR has higher P/E ratio than XCUR: XFOR (0.71) vs XCUR (0.19). XCUR YTD gains are higher at: -73.519 vs. XFOR (-86.210). XCUR has higher annual earnings (EBITDA): -12.42M vs. XFOR (-91.11M). XFOR has more cash in the bank: 63M vs. XCUR (7.86M). XCUR has less debt than XFOR: XCUR (476K) vs XFOR (78M). XFOR has higher revenues than XCUR: XFOR (32.8M) vs XCUR (0).
XCURXFORXCUR / XFOR
Capitalization25.3M72.1M35%
EBITDA-12.42M-91.11M14%
Gain YTD-73.519-86.21085%
P/E Ratio0.190.7126%
Revenue032.8M-
Total Cash7.86M63M12%
Total Debt476K78M1%
FUNDAMENTALS RATINGS
XCUR vs XFOR: Fundamental Ratings
XCUR
XFOR
OUTLOOK RATING
1..100
5078
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
6564
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XCUR's Valuation (36) in the null industry is somewhat better than the same rating for XFOR (71) in the Biotechnology industry. This means that XCUR’s stock grew somewhat faster than XFOR’s over the last 12 months.

XCUR's Profit vs Risk Rating (100) in the null industry is in the same range as XFOR (100) in the Biotechnology industry. This means that XCUR’s stock grew similarly to XFOR’s over the last 12 months.

XCUR's SMR Rating (99) in the null industry is in the same range as XFOR (100) in the Biotechnology industry. This means that XCUR’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's Price Growth Rating (64) in the Biotechnology industry is in the same range as XCUR (65) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

XFOR's P/E Growth Rating (100) in the Biotechnology industry is in the same range as XCUR (100) in the null industry. This means that XFOR’s stock grew similarly to XCUR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
XCURXFOR
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 23 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 6 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
XCUR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XFOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRWV120.862.11
+1.78%
Coreweave Inc
NJR46.410.36
+0.78%
New Jersey Resources Corp
MYFW22.790.09
+0.37%
First Western Financial
CCM5.65-0.10
-1.74%
Concord Medical Services Holding Limited
SION22.22-1.05
-4.51%
Sionna Therapeutics Inc

XCUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XCUR has been loosely correlated with XFOR. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if XCUR jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XCUR
1D Price
Change %
XCUR100%
-9.50%
XFOR - XCUR
34%
Loosely correlated
-5.45%
ALNY - XCUR
26%
Poorly correlated
-2.06%
NNVC - XCUR
25%
Poorly correlated
-0.69%
PLX - XCUR
25%
Poorly correlated
-4.10%
KRYS - XCUR
24%
Poorly correlated
-0.17%
More